1-4 of 4
Hakan Akbulut
Close
Sort by
Journal Articles

Vector Prime-Protein Boost Vaccine Induces 20 Fold Decrease in the Levels of CD44 + CD24 −/Low Cancer Stem Cells in Epithelial Neoplasms

Yucheng Tang, MD, PhD, Hakan Akbulut, MD, Jonathan Maynard, Pingchaun Li, PhD, Albert B. Deisseroth, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2908.
https://doi.org/10.1182/blood.V112.11.2908.2908
Published: 2008
Journal Articles

TAA/ecdCD40L VPP Vaccination Induces Robust Adaptive Immune Response Even in Individuals with Post Transplantation Lymphopenia

Tae Hae Han, MD, PhD, Yucheng Tang, MD, PhD, Yeon Hee Park, MD, Jonathan Maynard, Pingchuan Li, PhD, Hakan Akbulut, MD, Line Petersen, Albert B. Deisseroth, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 363.
https://doi.org/10.1182/blood.V112.11.363.363
Published: 2008
Journal Articles

Vector Prime-Protein Boost Vaccine Induces Immune Response Against “Self-Antigens” Associated with Epithelial Neoplasms and Tumor Vascular Endothelial Cells.

Yucheng Tang, MD, PhD, Jonathan Maynard, Hakan Akbulut, MD, Phyllis-Jean Linton, PhD, Albert B. Deisseroth, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5533.
https://doi.org/10.1182/blood.V106.11.5533.5533
Published: 2005
Journal Articles

Multistep process through which adenoviral vector vaccine overcomes anergy to tumor-associated antigens

Yucheng Tang, Lixin Zhang, Jing Yuan, Hakan Akbulut, Jonathan Maynard, Phyllis-Jean Linton, Albert Deisseroth
Journal: Blood
Blood (2004) 104 (9): 2704–2713.
https://doi.org/10.1182/blood-2003-12-4319
Published: 2004